The Gates Foundation is spending $40 million on countries in Africa and other economically backward nations to produce new mRNA vaccines in efforts to prevent against diseases like tuberculosis and malaria.
On Monday, the Bill & Melinda Gates Foundation announced $40 million in funding to "advance access to mRNA research and vaccine manufacturing technology that will support low-and middle-income countries’ (LMICs) capacity to develop high-quality, lifesaving vaccines at scale," according to an Oct. 9 press release. The $40 million will be spent on boosting access to a low-cost mRNA research and manufacturing platform developed by Belgium-based Quantoom Biosciences.
While $20 million will go to Quantoom, two research institutes in Africa—located in Senegal and South Africa—will get $5 million each. The remaining $10 million will go to vaccine manufacturers from low- and middle-income countries.
Quantoom’s platform can lead to a more than 50 percent drop in mRNA vaccine development costs compared to traditional mRNA technology, the release said.
Poster Comment:
Africans did not take the covid clot shot so few died. Gates needs them to take his bioweapons!